Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
C$0.07
-12.5%
C$0.07
C$0.07
C$0.11
C$943K0.4922,531 shs1,000 shs
Meritage Homes Co. stock logo
MTH
Meritage Homes
$181.20
+2.1%
$196.48
$109.23
$213.98
$6.58B1.8409,820 shs694,036 shs
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
$0.07
-26.4%
$0.18
$0.07
$4.31
$1.16M-0.483.71 million shs9.45 million shs
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
$31.44
$31.75
$15.24
$34.24
$4.01B1.571.25 million shs26.46 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
0.00%0.00%0.00%0.00%0.00%
Meritage Homes Co. stock logo
MTH
Meritage Homes
-1.59%-3.14%-13.41%-9.34%+55.60%
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
+4.44%-12.07%-6.00%-83.66%+9,399,900.00%
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
N/AN/AN/AN/AN/AN/AN/AN/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
3.6826 of 5 stars
2.34.02.50.02.62.51.9
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/AN/AN/AN/A
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
N/AN/AN/AN/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
2.50
Moderate Buy$220.1721.50% Upside
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/A
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
N/AN/AN/AN/A

Current Analyst Ratings

Latest MTH, DCY, PBM, and WRI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/31/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$205.00 ➝ $235.00
10/15/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral$160.00 ➝ $195.00
8/14/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$230.00
7/31/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$220.00 ➝ $230.00
(Data available from 10/31/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
N/AN/AC$0.00 per share35.00C($0.02) per shareN/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
$6.46B1.02$20.64 per share8.78$126.53 per share1.43
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/A($0.82) per shareN/A
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
$433.92M9.25$2.02 per share15.53$13.95 per share2.25

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
N/A-C$0.02N/AN/AN/A-833.85%-182.27%N/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
$738.75M$21.447.978.24N/A12.98%17.99%12.92%1/29/2025 (Estimated)
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
-$51.16MN/A0.00N/AN/AN/AN/AN/A
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
$112.15M$1.6544.9117.182.7118.97%4.93%2.27%N/A

Latest MTH, DCY, PBM, and WRI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2024Q3 2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
$5.05$5.34+$0.29$5.34$1.58 billion$1.59 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
N/A9.96%N/AN/AN/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
$3.001.66%N/A13.99%N/A
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/AN/AN/AN/AN/A
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
$0.922.93%N/A55.76%N/A

Latest MTH, DCY, PBM, and WRI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/29/2024
Meritage Homes Co. stock logo
MTH
Meritage Homes
quarterly$0.751.3%9/16/20249/16/20249/30/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
N/A
0.07
0.36
Meritage Homes Co. stock logo
MTH
Meritage Homes
0.27
1.93
1.93
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/A
0.09
0.09
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
1.00
1.62
1.58

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
N/A
Meritage Homes Co. stock logo
MTH
Meritage Homes
98.44%
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
77.44%
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
85.19%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Discovery-Corp Enterprises Inc. stock logo
DCY
Discovery-Corp Enterprises
N/A13.47 millionN/ANot Optionable
Meritage Homes Co. stock logo
MTH
Meritage Homes
1,92036.32 million35.60 millionOptionable
Psyence Biomedical Ltd. stock logo
PBM
Psyence Biomedical
N/A16.70 million16.10 millionN/A
Weingarten Realty Investors stock logo
WRI
Weingarten Realty Investors
243127.63 millionN/AOptionable

MTH, DCY, PBM, and WRI Headlines

Recent News About These Companies

American Realty Investors Inc ARL
Investors Edge Real Estate
On Randi Weingarten’s Waterfront
Randi Weingarten is the shame of the nation
Understanding the 1% rule for real estate investors
What ESG Means for Real Estate Investors
TCI

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Discovery-Corp Enterprises logo

Discovery-Corp Enterprises

CVE:DCY
Discovery-Corp Enterprises Inc., an exploration stage company, explores for base and precious metals in Canada. The company focuses on gold and copper properties. It holds a 100% interest in the Galaxy property comprising seven mineral claims and two crown-granted mineral claims covering an area of 91 hectares located in the Kamloops Mining Division of British Columbia, Canada. It also holds an undivided 50% interest in the mineral rights associated with Rock Creek Ranch property located in Humboldt County, Nevada, the United States. The company was formerly known as Getchell Resources Incorporated and changed its name to Discovery-Corp Enterprises Inc. in 2000. Discovery-Corp Enterprises Inc. was incorporated in 1986 and is headquartered in Vancouver, Canada.
Meritage Homes logo

Meritage Homes

NYSE:MTH
Meritage Homes Corporation, together with its subsidiaries, designs and builds single-family attached and detached homes in the United States. The company operates through two segments, Homebuilding and Financial Services. It acquires and develops land; and constructs, markets, and sells homes for entry-level and first move-up buyers in Arizona, California, Colorado, Utah, Texas, Florida, Georgia, North Carolina, South Carolina, and Tennessee. The company also offers title and escrow, mortgage, insurance, and closing/settlement services to its homebuyers. Meritage Homes Corporation was founded in 1985 and is based in Scottsdale, Arizona.
Psyence Biomedical logo

Psyence Biomedical

NASDAQ:PBM
Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.
Weingarten Realty Investors logo

Weingarten Realty Investors

NYSE:WRI
Weingarten Realty Investors (NYSE: WRI) is a shopping center owner, manager and developer. At September 30, 2020, the Company owned or operated under long-term leases, either directly or through its interest in real estate joint ventures or partnerships, a total of 162 properties which are located in 15 states spanning the country from coast to coast. These properties represent approximately 31.0 million square feet of which our interests in these properties aggregated approximately 21.0 million square feet of leasable area.